Cover of Aspirinkey genes could point to new treatments
Considered as the 'biggest break-through in 15 years' the UK discovery of 3 potential key genes could help cut the number of people developing Alzheimers by up to a fifth, claim the Alzheimer's Research Trust.
This is very exciting news, as it is said that between 60-80 per cent of a person's risk of developing Alzheimer's is genetic. This could lead to further breakthroughs in treatment.
The research has also found that inflammation appears to be the primary cause of the disease not secondary as initially considered. This means that anti-inflammatory medicines such as Aspirin could be a simple and cheap way of fighting the onset of this terrible disease. In fact adults over 50 are now regularly advised to take Aspirin to reduce the risk of heart attacks and stroke, so possibly some retrospective studies to look at incidence of disease development in people who have been prescribed Aspirin, with a family history of Alzheimers maybe a helpful study.
Further a Cancer drug has also been associated with restoring short term memory. As this drug is already approved this coud allow patient trials to begin within the next couple of years, which is very encouraging news indeed.
This is very exciting news, as it is said that between 60-80 per cent of a person's risk of developing Alzheimer's is genetic. This could lead to further breakthroughs in treatment.
The research has also found that inflammation appears to be the primary cause of the disease not secondary as initially considered. This means that anti-inflammatory medicines such as Aspirin could be a simple and cheap way of fighting the onset of this terrible disease. In fact adults over 50 are now regularly advised to take Aspirin to reduce the risk of heart attacks and stroke, so possibly some retrospective studies to look at incidence of disease development in people who have been prescribed Aspirin, with a family history of Alzheimers maybe a helpful study.
Further a Cancer drug has also been associated with restoring short term memory. As this drug is already approved this coud allow patient trials to begin within the next couple of years, which is very encouraging news indeed.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=3811ec24-517b-4b1a-9354-a565dcdfe0d0)
Any research that provides additional insight into Alzheimer’s is critical to finding a cure. It is also important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. One such study is the ICARA Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.
ReplyDeleteAny research that provides insight into Alzheimer’s is critical to finding a cure. It is important for patients and families affected by Alzheimer’s to consider participating in clinical studies. One such study is the ICARA Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease.
ReplyDelete